These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16962473)

  • 21. Stress echocardiography for assessment of cardiac allograft vasculopathy.
    Spes CH; Angermann CE
    Z Kardiol; 2000; 89 Suppl 9():IX/50-3. PubMed ID: 11151793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy.
    Sade LE; Eroğlu S; Yüce D; Bircan A; Pirat B; Sezgin A; Aydınalp A; Müderrisoğlu H
    J Am Soc Echocardiogr; 2014 May; 27(5):531-9. PubMed ID: 24613313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound.
    Spes CH; Mudra H; Schnaack SD; Klauss V; Reichle FM; Uberfuhr P; Theisen K; Angermann CE
    Am J Cardiol; 1996 Jul; 78(2):168-74. PubMed ID: 8712138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy.
    Acevedo MJ; Caro-Oleas JL; Álvarez-Márquez AJ; Sobrino JM; Lage-Gallé E; Aguilera I; Núñez-Roldán A
    J Heart Lung Transplant; 2011 Sep; 30(9):1051-9. PubMed ID: 21489814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Variability of transplant vasculopathy. A study with intravascular ultrasound].
    Klauss V; Rieber J; Uberfuhr P; Theisen K; Mudra H
    Z Kardiol; 1995 Feb; 84(2):121-9. PubMed ID: 7717015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.
    Foldyna B; Sandri M; Luecke C; Garbade J; Gohmann R; Hahn J; Fischer J; Gutberlet M; Lehmkuhl L
    Eur Radiol; 2020 Aug; 30(8):4317-4326. PubMed ID: 32179995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation.
    Potena L; Masetti M; Sabatino M; Bacchi-Reggiani ML; Pece V; Prestinenzi P; Dall'Ara G; Taglieri N; Saia F; Fallani F; Magnani G; Rapezzi C; Grigioni F
    J Heart Lung Transplant; 2015 Sep; 34(9):1146-53. PubMed ID: 25843518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
    Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
    J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do cardiovascular risk factors influence cardiac allograft vasculopathy?
    Chamorro CI; Almenar L; Martínez-Dolz L; Sánchez-Lacuesta E; Martín-Pastor J; Ten-Morro F; Sánchez-Soriano RM; Agüero J; Ortiz V; Moro JA; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2572-4. PubMed ID: 17098006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvasculopathy observed in early or late endomyocardial biopsies is not related to angiographically confirmed transplanted heart coronary vasculopathy.
    Zakliczyński M; Konecka-Mrówka D; Lekston A; Nozyński J; Pyka L; Trybunia D; Swierad M; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3209-13. PubMed ID: 19857712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of dual source computed tomography versus intravascular ultrasound for evaluation of coronary arteries at least one year after cardiac transplantation.
    Schepis T; Achenbach S; Weyand M; Raum P; Marwan M; Pflederer T; Daniel WG; Tandler R; Kondruweit M; Ropers D
    Am J Cardiol; 2009 Nov; 104(10):1351-6. PubMed ID: 19892049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravascular ultrasound for assessment of coronary allograft vasculopathy.
    König A; Theisen K; Klauss V
    Z Kardiol; 2000; 89 Suppl 9():IX/45-9. PubMed ID: 11151792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of dobutamine stress echocardiography in the detection of cardiac allograft vasculopathy in heart transplant recipients: A systematic review and meta-analysis study.
    Elkaryoni A; Abu-Sheasha G; Altibi AM; Hassan A; Ellakany K; Nanda NC
    Echocardiography; 2019 Mar; 36(3):528-536. PubMed ID: 30726558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Young JB; Crowe T; Ratliff NB; Cook DJ; Hobbs R; Bott-Silverman C; Rincon G; Smedira N; Tuzcu EM
    Transplant Proc; 2004 Dec; 36(10):3129-31. PubMed ID: 15686711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation.
    Hollenberg SM; Klein LW; Parrillo JE; Scherer M; Burns D; Tamburro P; Bromet D; Satran A; Costanzo MR
    J Heart Lung Transplant; 2004 Mar; 23(3):265-71. PubMed ID: 15019634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients.
    De Chiara B; Bigi R; Campolo J; Parolini M; Turazza F; Masciocco G; Frigerio M; Fiorentini C; Parodi O
    Clin Transplant; 2005 Jun; 19(3):367-71. PubMed ID: 15877800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography.
    Derumeaux G; Redonnet M; Soyer R; Cribier A; Letac B
    J Heart Lung Transplant; 1998 Mar; 17(3):259-67. PubMed ID: 9563602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.